Equities

Kintor Pharmaceutical Ltd

Kintor Pharmaceutical Ltd

Actions
  • Price (HKD)0.92
  • Today's Change-0.02 / -2.13%
  • Shares traded714.00k
  • 1 Year change-68.28%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4568751,055
Total Receivables, Net8.661.930.69
Total Inventory0604351
Prepaid expenses5.3920115
Other current assets, total2.177.323.60
Total current assets4731,5081,526
Property, plant & equipment, net222285267
Goodwill, net------
Intangibles, net149236236
Long term investments1818--
Note receivable - long term7.849.0039
Other long term assets------
Total assets8692,0552,068
LIABILITIES
Accounts payable13102128
Accrued expenses151622
Notes payable/short-term debt20400
Current portion long-term debt/capital leases98639.47
Other current liabilities, total799660
Total current liabilities225318220
Total long term debt136183150
Total debt254286160
Deferred income tax313939
Minority interest------
Other liabilities, total20204.01
Total liabilities411560413
SHAREHOLDERS EQUITY
Common stock0.320.320.27
Additional paid-in capital4,1824,1043,359
Retained earnings (accumulated deficit)(3724)(2609)(1704)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity4581,4951,655
Total liabilities & shareholders' equity8692,0552,068
Total common shares outstanding447447388
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.